Pilot Aims To Help Manufacturers Measure Quality Culture
Parenteral Drug Association is testing a program that links behaviors that cannot be measured to quality attributes that can be evaluated. Despite the US FDA’s move to drop quality culture as a metric in a recent guidance, pharma manufacturers are urged to evaluate it anyway to help avoid compliance failures.
You may also be interested in...
US FDA will establish mandatory quality metrics reporting through a formal rulemaking process that could take years. Meanwhile, a revised draft guidance lays out plans for voluntary quality metrics reporting that could begin by January 2018.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.